Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is Anticipated to Attain a Valuation of US$ 39.5 Bn Steady CAGR of 4.7% by the end of year 2028. Analysis by Future Market Insights, Inc. NEWARK, Del, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia (BPH) prostate treatment market is expected to reach a valuation of US$ 39.5 Bn in 2028, with demand growing at...

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market to expand at a CAGR of 4.6% by 2028- Future Market Insights VALLEY COTTAGE, N.Y. , March 12, 2019 (GLOBE NEWSWIRE) -- The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028,...